# Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung

Study · id `cardio:ct-nct05657769` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05657769](<https://clinicaltrials.gov/study/NCT05657769>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05657769

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

## Technical summary

Registry record NCT05657769. Randomized; no masking; primary purpose supportive care. Start 2022-11-12 (actual); primary completion 2023-05-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT05657769, source copy `cardio:ctgov-nct05657769-2023-04-19`, retrieved 2026-10-26)
- Started: 2022-11-12 (actual) (ClinicalTrials.gov record NCT05657769, source copy `cardio:ctgov-nct05657769-2023-04-19`, retrieved 2026-10-26)
- Primary completion: 2023-05-30 (anticipated) (ClinicalTrials.gov record NCT05657769, source copy `cardio:ctgov-nct05657769-2023-04-19`, retrieved 2026-10-26)
- Completion: 2023-05-30 (anticipated) (ClinicalTrials.gov record NCT05657769, source copy `cardio:ctgov-nct05657769-2023-04-19`, retrieved 2026-10-26)
- Countries: Indonesia (ClinicalTrials.gov record NCT05657769, source copy `cardio:ctgov-nct05657769-2023-04-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05657769-2023-04-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung
- Condition: Diabetes Mellitus, Type 2
- Intervention (Device): Medwell Preventive Care Application
- Intervention (Device): Manual Records
- Lead sponsor: PT Bio Farma
- Lead sponsor class: INDUSTRY
- Collaborator: Immanuel Hospital, Berlin, Germany
- Collaborator class: OTHER
- Collaborator: Prodia the CRO
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 8e5944dcc52dfbb2101ac3e94a6429b91faf8b58bd1df54c1590af2ee7906c36
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
